SITAGLIPTINE HCS 100 mg, film-coated tablet scored 30 tablets
Active ingredients: Sitagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SITAGLIPTINE HCS 100 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- HCS (BELGIQUE)
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66801671CIP73025907CIP133400930259078Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SITAGLIPTINEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: SITAGLIPTINE (PHOSPHATE DE) MONOHYDRATE équivalant à SITAGLIPTINE 100 mg - SITAGLIPTINE (MALATE DE) équivalant à SITAGLIPTINE 100 mg - JANUVIA 100 mg, comprimé pelliculé
